These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23494814)

  • 21. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
    Hwang KO; Kolarov S; Cheng L; Griffith RA
    J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National survey of stress ulcer prophylaxis.
    Lam NP; Lê PD; Crawford SY; Patel S
    Crit Care Med; 1999 Jan; 27(1):98-103. PubMed ID: 9934901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
    Heidelbaugh JJ; Inadomi JM
    Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
    Hussain S; Stefan M; Visintainer P; Rothberg M
    South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying Risk Factors Associated with Inappropriate Use of Acid Suppressive Therapy at a Community Hospital.
    Singh A; Bodukam V; Saigal K; Bahl J; Wang Y; Hanlon A; Lu Y; Davis M
    Gastroenterol Res Pract; 2016; 2016():1973086. PubMed ID: 27818680
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
    Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
    Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.
    Li H; Li N; Jia X; Zhai Y; Xue X; Qiao Y
    Front Pharmacol; 2022; 13():881063. PubMed ID: 35721126
    [No Abstract]   [Full Text] [Related]  

  • 29. Acid suppressive therapy use on an inpatient internal medicine service.
    Pham CQ; Regal RE; Bostwick TR; Knauf KS
    Ann Pharmacother; 2006; 40(7-8):1261-6. PubMed ID: 16804095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.
    Nasser SC; Nassif JG; Dimassi HI
    World J Gastroenterol; 2010 Feb; 16(8):982-6. PubMed ID: 20180237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress Ulcer Prophylaxis in Hospitalized Patients, Subsequent Use in Primary Care, and Physicians' Opinions About Acid-Suppressive Therapy.
    Riaz M; Hughes S; Gomez IA; Mortimer RB
    South Med J; 2016 Mar; 109(3):158-64. PubMed ID: 26954653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit.
    Rafinazari N; Abbasi S; Farsaei S; Mansourian M; Adibi P
    J Res Pharm Pract; 2016; 5(3):186-92. PubMed ID: 27512710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.
    Scagliarini R; Magnani E; Praticò A; Bocchini R; Sambo P; Pazzi P
    Dig Dis Sci; 2005 Dec; 50(12):2307-11. PubMed ID: 16416179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.
    Ye Z; Reintam Blaser A; Lytvyn L; Wang Y; Guyatt GH; Mikita JS; Roberts J; Agoritsas T; Bertschy S; Boroli F; Camsooksai J; Du B; Heen AF; Lu J; Mella JM; Vandvik PO; Wise R; Zheng Y; Liu L; Siemieniuk RAC
    BMJ; 2020 Jan; 368():l6722. PubMed ID: 31907223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults.
    Hammond DA; Killingsworth CA; Painter JT; Pennick RE; Chatterjee K; Boye B; Meena N
    Pharm Pract (Granada); 2017; 15(3):948. PubMed ID: 28943978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study.
    Jones CA; Betthauser KD; Lizza BD; Juang PA; Micek ST; Kollef MH
    Hosp Pharm; 2022 Aug; 57(4):510-517. PubMed ID: 35898251
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.